Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 55,877 | 59,711 | 49,003 | 45,870 | 54,876 |
| Cost of Goods | 43,916 | 47,920 | 34,007 | 33,362 | 35,246 |
| Gross Profit | 11,961 | 11,791 | 14,996 | 12,508 | 19,646 |
| Operating Expenses | 19,902 | 20,528 | 16,175 | 14,839 | 16,952 |
| Operating Income | -7,025 | -7,817 | -1,172 | -1,969 | 2,924 |
| Interest Expense | -551 | 504 | 476 | 180 | 221 |
| Other Income | 657 | 337 | -228 | -322 | 79 |
| Pre-tax Income | -5,817 | -7,984 | -1,876 | -2,471 | 2,782 |
| Income Tax | -3,296 | -2,605 | -696 | -852 | 953 |
| Net Income Continuous | -2,521 | -5,379 | -1,180 | -1,619 | 1,829 |
| Net Income | $-2,521 | $-5,379 | $-1,180 | $-1,619 | $1,829 |
| EPS Basic Total Ops | -0.06 | -0.12 | -0.03 | -0.04 | 0.05 |
| EPS Basic Continuous Ops | -0.06 | -0.12 | -0.03 | -0.04 | 0.05 |
| EPS Diluted Total Ops | -0.06 | -0.12 | -0.03 | -0.04 | 0.05 |
| EPS Diluted Continuous Ops | -0.06 | -0.12 | -0.03 | -0.04 | 0.05 |
| EBITDA(a) | $-3,249 | $-4,137 | $2,405 | $1,446 | $6,385 |